Synonyms:bupivacaine, 2180-92-9, 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide, DL-Bupivacaine, 38396-39-3, Marcaine, Bupivacaina, Anekain, (+-)-Bupivacaine, Bupivacainum, Sensorcaine, 1-Butyl-2',6'-pipecoloxylidide, Exparel, Bupivacainum [INN-Latin], Bupivacaina [INN-Spanish], dl-1-Butyl-2',6'-pipecoloxylidide, AH 250, Bucaine, 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, Win 11318, Bloqueina, (+/-)-Bupivacaine, Posimir, SKY0402, 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide, 2',6'-Pipecoloxylidide, 1-butyl-, 1-butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide, Marcain, LIQ865, (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide, CHEBI:77431, LIQ-865, SKY-0402, Xaracoll, LAC-43, Y8335394RO, cBupivacaine, Bupivacaine HCL KIT, bupivacaine base, (R)-Bupivacaine HCl, Bucaine (TN), DUR-843, EINECS 218-553-3, EINECS 253-911-2, Bupivacaine [USAN:INN:BAN], UNII-Y8335394RO, HSDB 7790, racemic bupivacaine, (RS)-bupivacaine, Bupivacaine liposome, SKY 0402, Exparel (TN), Liposomal bupivacaine, Bupivacaine Free Base, Bupivacaine-[13C], Spectrum_001524, Bupivacaine liposome injectable suspension, Marcaine and Sensorcaine, BUPIVACAINE [MI], Prestwick0_000305, Prestwick1_000305, Prestwick2_000305, Prestwick3_000305, Spectrum2_001589, Spectrum3_000974, Spectrum4_001098, Spectrum5_001483, BUPIVACAINE [INN], (.+/-.)-1-Butyl-2',6'-pipecoloxylidide, (.+/-.)-Bupivacaine, Bupivacaine (USAN/INN), BUPIVACAINE [HSDB], BUPIVACAINE [USAN], LAC-43 (Salt/Mix), Epitope ID:122662, BUPIVACAINE [VANDF], Marcaine spinal (Salt/Mix), CHEMBL1098, SCHEMBL25438, BSPBio_000270, BSPBio_002607, BUPIVACAINE [WHO-DD], KBioGR_001516, KBioSS_002004, DivK1c_000758, SPBio_001558, SPBio_002489, BPBio1_000298, CHEBI:3215, GTPL2397, BUPIVACAINE [GREEN BOOK], DTXSID2022703, KBio1_000758, KBio2_002004, KBio2_004572, KBio2_007140, KBio3_001827, BUPIVACAINE [ORANGE BOOK], dl-1-Butyl-2,6-pipecoloxylidide, NINDS_000758, 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboximidic acid, AH250, HMS2090F12, HMS3428P06, Marcaine hydrochloride (Salt/Mix), 1217442-06-2, 3-Ethyl-2-methylbenzoxazoliumiodide, BCP12242, BCP21825, HY-B0405, 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-, AH-250, BDBM50350790, MFCD00243007, STL484283, ZYNRELEF COMPONENT BUPIVACAINE, AKOS001637202, AKOS016842516, AC-2096, BS-5224, CS-W023182, DB00297, BUPIVACAINE COMPONENT OF ZYNRELEF, IDI1_000758, NCGC00178579-01, NCGC00178579-02, BB166160, SBI-0051846.P002, DB-119016, AB00053674, FT-0623286, FT-0660567, FT-0699781, FT-0771900, C07529, D07552, Ropivacaine hydrochloride impurity, bupivacaine-, AB00053674-08, AB00053674-09, AB00053674_10, AB00053674_11, A873847, EN300-18292932, L000695, Q422806, Q-100271, BRD-A01636364-003-05-2, BRD-A01636364-003-08-6, (plusmn)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide, 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+/-)-, 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (.+/-.)-, ROPIVACAINE HYDROCHLORIDE IMPURITY, BUPIVACAINE- [USP IMPURITY], 119427-31-5
Pubchem:PUBCHEM:2474
Id:753329f0-fed7-5ece-ad01-674f07f72d7e
Description:nan
